Search research articles
Contact Us
Filters
Showing results (51-60 of 76) with videos related to
Page
of 8
Sort By:
Molecular Pharmacology
|
March 14, 1998
Mining the National Cancer Institute Anticancer Drug Discovery Database: cluster analysis of ellipticine analogs with p53-inverse and central nervous system-selective patterns of activity
L M Shi, T G Myers, Y Fan, et al.
Journal of Chemical Information and Computer Sciences
|
April 16, 1998
Mining the NCI anticancer drug discovery databases: genetic function approximation for the QSAR study of anticancer ellipticine analogues
L M Shi, Y Fan, T G Myers, et al.
American Journal of Human Genetics
|
March 1, 1995
Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome
T Frebourg, N Barbier, Y X Yan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 15, 1992
Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein
T Frebourg, J Kassel, K T Lam, et al.
The EMBO Journal
|
February 28, 1998
Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpoints
W A Cliby, C J Roberts, K A Cimprich, et al.
Cancer Research
|
February 15, 1996
An abnormality in the p53 pathway following gamma-irradiation in many wild-type p53 human melanoma lines
I Bae, M L Smith, M S Sheikh, et al.
Journal of Virology
|
March 1, 1990
Large T antigens of many polyomaviruses are able to form complexes with the retinoblastoma protein
N Dyson, R Bernards, S H Friend, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1991
Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations
A L Børresen, E Hovig, B Smith-Sørensen, et al.
Developmental Biology
|
September 1, 1992
Structure and expression of the Xenopus retinoblastoma gene
O H Destrée, K T Lam, L J Peterson-Maduro, et al.
Cancer Research
|
February 10, 2000
Differential toxicities of anticancer agents among DNA repair and checkpoint mutants of Saccharomyces cerevisiae
J A Simon, P Szankasi, D K Nguyen, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 76) with videos related to
Sort By:
Page
of 8
Molecular Pharmacology
|
March 14, 1998
Mining the National Cancer Institute Anticancer Drug Discovery Database: cluster analysis of ellipticine analogs with p53-inverse and central nervous system-selective patterns of activity
L M Shi, T G Myers, Y Fan, et al.
Journal of Chemical Information and Computer Sciences
|
April 16, 1998
Mining the NCI anticancer drug discovery databases: genetic function approximation for the QSAR study of anticancer ellipticine analogues
L M Shi, Y Fan, T G Myers, et al.
American Journal of Human Genetics
|
March 1, 1995
Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome
T Frebourg, N Barbier, Y X Yan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 15, 1992
Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein
T Frebourg, J Kassel, K T Lam, et al.
The EMBO Journal
|
February 28, 1998
Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpoints
W A Cliby, C J Roberts, K A Cimprich, et al.
Cancer Research
|
February 15, 1996
An abnormality in the p53 pathway following gamma-irradiation in many wild-type p53 human melanoma lines
I Bae, M L Smith, M S Sheikh, et al.
Journal of Virology
|
March 1, 1990
Large T antigens of many polyomaviruses are able to form complexes with the retinoblastoma protein
N Dyson, R Bernards, S H Friend, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1991
Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations
A L Børresen, E Hovig, B Smith-Sørensen, et al.
Developmental Biology
|
September 1, 1992
Structure and expression of the Xenopus retinoblastoma gene
O H Destrée, K T Lam, L J Peterson-Maduro, et al.
Cancer Research
|
February 10, 2000
Differential toxicities of anticancer agents among DNA repair and checkpoint mutants of Saccharomyces cerevisiae
J A Simon, P Szankasi, D K Nguyen, et al.
Page
of 8